Mar 19, 2019 · The FDA approved the first postpartum depression drug called Zulresso. Sage Therapeutics's stock jumped 5 percent on the news. Two clinical studies showed that Zulresso was superior to placebo and Sage Therapeutics, Inc. - SAGE - Stock Price Today - Zacks View Sage Therapeutics, Inc. SAGE investment & stock information. Get the latest Sage Therapeutics, Inc. SAGE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Press Releases | Sage Therapeutics, Inc. CAMBRIDGE, Mass. --(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced that on March 2, 2020 , the Compensation Sage's Postpartum Depression Drug Likely To Catalyze Stock He has an 84 price target on Sage stock, though he sees a risk of shares falling as low as 20 if Sage's STATUS trial — the trial examining SAGE-547 for PPD and SRSE — misses its primary endpoints. Sage Therapeutics Inc. (SAGE) Stock Chart

SAGE Stock Price, Forecast & News (SAGE Therapeutics)

Sage Therapeutics Inc., SAGE Quick Chart - (NAS) SAGE ... Sage Therapeutics stock price target cut to $70 from $210 at SunTrust RH MarketWatch. 06:45 AM ET. Sage Therapeutics stock price target cut to $105 from $200 at J.P. Morgan MarketWatch. Thursday, December 05, 2019. 03:40 PM ET. Sage Therapeutics Shares Plummet on Depression-Treatment Study Results The Wall Street Journal Interactive Edition. 12 SAGE - SAGE Therapeutics Inc Stock quote - CNNMoney.com Find real-time SAGE - SAGE Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Sage Therapeutics, Inc. (SAGE) Stock Analysis & News ...

Sage Therapeutics Inc., SAGE Quick Chart - (NAS) SAGE ...

SAGE Therapeutics Inc. is a biopharmaceutical company developing and commercializing medicines to treat life-threatening central nervous system (CNS)   Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it  SAGE, Sage Therapeutics Inc - Stock quote performance, technical chart analysis , SmartSelect Ratings, Group Leaders and the latest company headlines. Stock Price Forecast for SAGE: Sage Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or   Company Name: Sage Therapeutics Inc., Stock Symbol: SAGE, Industry: Biotechs, Total Posts: 114, Last Post: 2/12/2020 11:51:20 AM.

Oct 29, 2019 · SAGE, Sage Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines

102 rows · Discover historical prices for SAGE stock on Yahoo Finance. View daily, weekly or monthly … Careers at Sage Therapeutics | Sage Therapeutics job ... It’s time to discover your future with Sage. We are Sage Therapeutics, and we're on a fiercely committed journey of discovery, with the ultimate aim of truly enhancing the … Sage Therapeutics stock rises after FDA approves ... - CNBC Mar 19, 2019 · The FDA approved the first postpartum depression drug called Zulresso. Sage Therapeutics's stock jumped 5 percent on the news. Two clinical studies showed that Zulresso was superior to placebo and Sage Therapeutics, Inc. - SAGE - Stock Price Today - Zacks View Sage Therapeutics, Inc. SAGE investment & stock information. Get the latest Sage Therapeutics, Inc. SAGE detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

SAGE Therapeutics, Inc. - TheStreet - Stock Market

Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it  SAGE, Sage Therapeutics Inc - Stock quote performance, technical chart analysis , SmartSelect Ratings, Group Leaders and the latest company headlines. Stock Price Forecast for SAGE: Sage Therapeutics holds several negative signals and we believe that it will still perform weakly in the next couple of days or   Company Name: Sage Therapeutics Inc., Stock Symbol: SAGE, Industry: Biotechs, Total Posts: 114, Last Post: 2/12/2020 11:51:20 AM. 16 Mar 2020 Given the most recent momentum in the market in the price movement of SAGE stock, some strong opinions on the matter of investing in the 

Sage Therapeutics stock price target cut to $70 from $210 at SunTrust RH MarketWatch. 06:45 AM ET. Sage Therapeutics stock price target cut to $105 from $200 at J.P. Morgan MarketWatch. Thursday, December 05, 2019. 03:40 PM ET. Sage Therapeutics Shares Plummet on Depression-Treatment Study Results The Wall Street Journal Interactive Edition. 12